Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Opko Health Inc (NASDAQ: OPK) was $1.34 for the day, up 2.29% from the previous closing price of $1.31. In other words, the price has increased by $2.29 from its previous closing price. On the day, 1.26 million shares were traded. OPK stock price reached its highest trading level at $1.36 during the session, while it also had its lowest trading level at $1.29.
Ratios:
Our analysis of OPK’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.62 and its Current Ratio is at 1.91. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.31.
On December 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $3.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 31 ’24 when OPKO HEALTH, INC. sold 88,839 shares for $33.50 per share. The transaction valued at 2,976,346 led to the insider holds 2,984,564 shares of the business.
OPKO HEALTH, INC. sold 50,000 shares of OPK for $1,692,890 on Jul 29 ’24. The 10% Owner now owns 3,073,403 shares after completing the transaction at $33.86 per share. On Jul 26 ’24, another insider, OPKO HEALTH, INC., who serves as the 10% Owner of the company, sold 60,000 shares for $33.85 each. As a result, the insider received 2,031,258 and left with 3,123,403 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OPK now has a Market Capitalization of 933969280 and an Enterprise Value of 1277906816. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 1.598 whereas that against EBITDA is -13.537.
Stock Price History:
Over the past 52 weeks, OPK has reached a high of $2.03, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is -0.33%, while the 200-Day Moving Average is calculated to be 6.85%.
Shares Statistics:
OPK traded an average of 3.37M shares per day over the past three months and 2217090 shares per day over the past ten days. A total of 773.28M shares are outstanding, with a floating share count of 325.06M. Insiders hold about 53.36% of the company’s shares, while institutions hold 25.66% stake in the company. Shares short for OPK as of 1721001600 were 83592139 with a Short Ratio of 24.79, compared to 1718323200 on 87483859. Therefore, it implies a Short% of Shares Outstanding of 83592139 and a Short% of Float of 22.559999.
Earnings Estimates
As of right now, 6.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.06 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.32 and -$0.49 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.24, with 5.0 analysts recommending between -$0.08 and -$0.35.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $191.6M to a low estimate of $182.5M. As of the current estimate, Opko Health Inc’s year-ago sales were $201.97MFor the next quarter, 5 analysts are estimating revenue of $174.33M. There is a high estimate of $192M for the next quarter, whereas the lowest estimate is $157.55M.
A total of 5 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $746.7M, while the lowest revenue estimate was $675.65M, resulting in an average revenue estimate of $711.01M. In the same quarter a year ago, actual revenue was $863.5MBased on 5 analysts’ estimates, the company’s revenue will be $746.03M in the next fiscal year. The high estimate is $827.4M and the low estimate is $658.35M.
